The Acute Decompensated Heart Failure National Registry (ADHERE™): Opportunities to improve care of patients hospitalized with acute decompensated heart failure

Reviews in Cardiovascular Medicine

Volumn 4, Issue SUPPL. 7, 2003, Pages

  Fonarow, Gregg C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute decompensated heart failure; ADHERE ; Hospitalization

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MILRINONE; NONSTEROID ANTIINFLAMMATORY AGENT; SODIUM; VASOACTIVE AGENT;

ADULT; ANAMNESIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; DRUG EFFICACY; FEMALE; HEALTH CARE QUALITY; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LONG TERM CARE; MALE; MORTALITY; PATIENT CARE; PATIENT EDUCATION; PRACTICE GUIDELINE; SODIUM BLOOD LEVEL; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL;

HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HOSPITALS; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT READMISSION; QUALITY ASSURANCE, HEALTH CARE; REGISTRIES; UNITED STATES;

EID: 0346271500     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2001;38:2101-2113.
2. American Heart Association. 2003 Heart and stroke statistical update. Dallas, Texas: American Heart Association, 2002.
3. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997;157:99-104.
4. Franciosa JA, Abraham WT, Fowler M, et al for the COHERE participating physicians. Rationale, design and methods for a coreg (carvedilol) heart failure registry (COHERE). J Card Fail. 2000;6:264-271.
5. Adams KF, O'Connor CM, Oren RM, et al. Development of a multicenter heart failure database: Initial report from the United Investigators to Evaluate Heart Failure. J Card Fail. 2000;6:2-56.
6. Fonarow GC, Adams K, Strausser PB. ADHERE (acutely decompensated heart failure national registry): rationale, design, and subject population. J Card Fail. 2002;8:S49.
7. The ADHERE™ Registry. First Quarter 2003 National Benchmark Report. www.adhereregistry.com. Fremont, CA: Scios Inc; July 2003.
8. Emerman CL, Peacock F, Fonarow GC. Effect of emergency department initiation of vasoactive infusion therapy on heart failure length of stay. Ann Emerg Med. 2002;40:S46.
9. Cuffe MS, Califf RM, Adams KF, et al. Short-term intravenous Milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287:1541-1548.
10. Abraham WT, Adams KF, Fonarow GC, et al for The ADHERE Scientific Advisory Committee and Investigators. Comparison of in-hospital mortality in patients treated with nesiritide vs. other parenteral vasoactive medications for acutely decompensated heart failure: an analysis from a large prospective registry database. J Card Fail. 2003;9:S49.
11. Fonarow GC, Gawlinski A, Cardin S, et al. Improved treatment of cardiovascular disease by implementation of a cardiac hospitalization atherosclerosis management program: CHAMP. Am J Cardiol. 2001;87:819-822.
12. Fonarow GC. The role of in-hospitalization of cardioprotective therapies to improve treatment rates and clinical outcomes. Rev Cardiovasc Med. 2002;3:S2-S10.
13. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30:725-732.
14. Pearson RR, Horne BD, Maycock CA, et al. An institutional heart failure medication program reduces future cardiovascular readmissions and mortality: an analysis of 19,083 heart failure patients. Circulation. 2001;104:17 (suppl II):II-838.
15. Bradley EH, Holmboe ES, Mattera JA, et al. A qualitative study of increasing beta-blocker use after myocardial infarction: why do some hospitals succeed? JAMA. 2001;285:2604-2611.